abnormal vascular permeability_Cdh5<tm3(Cdh5/Ctnna1)Dvst>/Cdh5<tm3(Cdh5/Ctnna1)Dvst>

http://metadb.riken.jp/0001619I129C57BL6Cdh5tm3Cdh5Ctnna1DvstCdh5tm3Cdh5Ctnna1DvstCdh5tm3Cdh5Ctnna1Dvst

abnormal vascular permeability_Cdh5<tm3(Cdh5/Ctnna1)Dvst>/Cdh5<tm3(Cdh5/Ctnna1)Dvst>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cadherin 5
  http://metadb.riken.jp/db/mgi_rdf/MGI:105057

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdh5<tm3(Cdh5/Ctnna1)Dvst>/Cdh5<tm3(Cdh5/Ctnna1)Dvst>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdh5<tm3(Cdh5/Ctnna1)Dvst>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal vascular permeability
  http://purl.obolibrary.org/obo/MP_0001619

文献

http://purl.org/net/cito/citesAsAuthority

• Dörte. Schulte, et.al., Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability., The EMBO journal, 2011, 30
  http://rdf.ncbi.nlm.nih.gov/pubmed/21857650